K2C8_XENLA
ID K2C8_XENLA Reviewed; 502 AA.
AC P08776;
DT 01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1988, sequence version 1.
DT 25-MAY-2022, entry version 103.
DE RecName: Full=Keratin, type II cytoskeletal 8;
DE AltName: Full=Cytokeratin-8;
DE Short=CK-8;
DE AltName: Full=Keratin-8;
DE Short=K8;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX PubMed=2428034; DOI=10.1073/pnas.83.17.6475;
RA Franz J.K., Franke W.W.;
RT "Cloning of cDNA and amino acid sequence of a cytokeratin expressed in
RT oocytes of Xenopus laevis.";
RL Proc. Natl. Acad. Sci. U.S.A. 83:6475-6479(1986).
CC -!- FUNCTION: Together with KRT19, helps to link the contractile apparatus
CC to dystrophin at the costameres of striated muscle. {ECO:0000250}.
CC -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC Keratin-8 associates with keratin-18 (By similarity). {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleoplasm
CC {ECO:0000250}. Nucleus matrix {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Expressed in oocytes, eggs, embryos, liver and
CC intestinal mucosa. {ECO:0000269|PubMed:2428034}.
CC -!- DEVELOPMENTAL STAGE: Synthesized in the oocyte in early and late
CC embryonic stages. {ECO:0000269|PubMed:2428034}.
CC -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC -!- SIMILARITY: Belongs to the intermediate filament family.
CC {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M13811; AAA49891.1; -; mRNA.
DR PIR; A23547; A23547.
DR AlphaFoldDB; P08776; -.
DR SMR; P08776; -.
DR PRIDE; P08776; -.
DR Proteomes; UP000186698; Genome assembly.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0045095; C:keratin filament; IEA:InterPro.
DR GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR InterPro; IPR018039; IF_conserved.
DR InterPro; IPR039008; IF_rod_dom.
DR InterPro; IPR032444; Keratin_2_head.
DR InterPro; IPR003054; Keratin_II.
DR Pfam; PF00038; Filament; 1.
DR Pfam; PF16208; Keratin_2_head; 1.
DR PRINTS; PR01276; TYPE2KERATIN.
DR SMART; SM01391; Filament; 1.
DR PROSITE; PS00226; IF_ROD_1; 1.
DR PROSITE; PS51842; IF_ROD_2; 1.
PE 2: Evidence at transcript level;
KW Coiled coil; Cytoplasm; Intermediate filament; Keratin; Nucleus;
KW Phosphoprotein; Reference proteome.
FT CHAIN 1..502
FT /note="Keratin, type II cytoskeletal 8"
FT /id="PRO_0000063743"
FT DOMAIN 99..410
FT /note="IF rod"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT REGION 1..98
FT /note="Head"
FT REGION 99..134
FT /note="Coil 1A"
FT REGION 135..151
FT /note="Linker 1"
FT REGION 152..243
FT /note="Coil 1B"
FT REGION 244..267
FT /note="Linker 12"
FT REGION 268..406
FT /note="Coil 2"
FT REGION 269..390
FT /note="Necessary for interaction with PNN"
FT /evidence="ECO:0000250"
FT REGION 407..502
FT /note="Tail"
FT SITE 350
FT /note="Stutter"
FT MOD_RES 13
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 26
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 37
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 40
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 425
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 428
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 436
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
FT MOD_RES 444
FT /note="Phosphoserine"
FT /evidence="ECO:0000250"
SQ SEQUENCE 502 AA; 55679 MW; 96249824FBE131F0 CRC64;
MSVRSTKVTY RTSSAAPRSG GFSSFSYSGA PMASRASSAS FSLGSSYGGA SRFGSGYRSG
FGGAGVGSAG ITSVSVNQSL LAPLNLEIDP SIQQVRTEEK EQIKTLNNKF ASFIDKVRFL
EQQNKMLETK WNLLQNQKTT RSNMDGMFEA YISNLRRQLD GLGQDKMRLE SELGNMQGLV
EDFKNKYEDE INRRTELENE FVLLKKDVDE AYMNKVQLEA RLEALTDEIN FLRQLYEEEL
REMQSQISDT SVVLSMDNNR SLDLDGIIAE VRAQYEDVAN KSRLEVENMY QVKYQELQTS
AGRYGDDLKN TKTEISELTR YTTRLQSEID ALKAQRANLE AQIAEAEERG ELALKDARNK
LAELEAALQK AKQDMSRQLR DYQELMNVKL ALDIEIATYR KLLEGEESRL ESGFQNLSIQ
TKTVSGVSSG FGGGISSGFS NGVSSGFGGG YGGGYGGGYS YSSNVSSYIG DTKTSKRRLL
VKTVETKDGR VLSESSDVFS KP